Benzinga's Weekend M&A Chatter

The following are the M&A deals, rumors and chatter circulating on Wall Street for Friday July 10 through Sunday July 12, 2015:

:

Patrick Drahi, CEO of France's Altice

said Friday, in an interview with the

, that he may pursue bids for Cablevision Systems Corporation

privately-held Cox. Drahi reportedly held talks with Time Warner Cable Inc.

prior to its announced merger with Charter Communications, Inc.

. Cablevision shares rose more than 7% Friday, closing at $26.67.

:

Shares of Bristol-Myers Squibb Company

rose Friday, on renewed takeover chatter involving Pfizer Inc.

. The rumored offering is said to be $80.00 per share. That rumor last surfaced in June. Bristol-Myers has been rumored to have its sights set on Celgene Corporation

for as much as $138.00 per share. Bristol-Myers shares rose 2% Friday, closing at $69.27.

:

Lockheed Martin Corporation

is in advanced talks to acquire the Sikorsky Helicopter s from United Technologies Corp. for more than $8 billion, according to sources as reported by the

on Friday.

had reported on July 8 that Lockheed and Textron Inc.

were the two finalists for the unit. Spokespersons for Lockheed and United Technologies declined comment. Lockheed Martin shares rose 1% Friday, closing at $194.19.

:

Edwards Lifesciences Corporation

announced Friday, that it has agreed to acquire privately held CardiAQ Valve Technologies, Inc., a company and developer of a transcatheter mitral valve replacement system. The purchase price is up to $400 million, including $350 million in cash at closing, and the remainder payable upon achievement of a European regulatory milestone. Edwards Lifesciences shares rose 1.5% Friday, closing at $147.16.

:

Black Hills Corp.

announced Sunday it is acquiring SourceGas Holdings LLC from investment funds managed by Alinda Capital Partners and GE Unit

GE Energy Financial Services for total consideration of $1.89 billion. That includes reimbursement of approximately $200 million in capital expenditures through closing and the assumption of $720 million of debt projected at closing. The deal is expected to close in H1 of 2016 Black Hills Lifesciences shares rose 1.5% Friday, closing at $46.84.